Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion
利妥昔单抗可能通过增强白血病细胞对 CAR-T 介导的细胞毒性的敏感性并减少 CAR-T 耗竭来改善 r/r B-ALL 的 CAR-T 治疗的临床结果
期刊:Cellular Oncology
影响因子:
doi:10.1007/s13402-024-00945-7
Yangzi Li, Qingya Cui, Sining Liu, Lingling Liu, Megyn Li, Jun Gao, Zheng Li, Wei Cui, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang